Clinical trials
Small Cell Lung Carcinoma trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 13 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
| Completed | 24 |
| Active, not recruiting | 16 |
| Terminated | 7 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 11 |
| AbbVie | 10 |
| Boehringer Ingelheim | 7 |
| Bristol-Myers Squibb | 5 |
| Pfizer | 5 |
| AstraZeneca | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Hoffmann-La Roche | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Daiichi Sankyo | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 74 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Neoplasms | 10 |
| Lung Neoplasms | 8 |
| Stomach Neoplasms | 7 |
| Ovarian Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Carcinoma, Merkel Cell | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma, Hepatocellular | 4 |
Trials
Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.